This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

GE Healthcare To Showcase Latest Innovations In Anesthesia Delivery And Patient Monitoring At ANESTHESIOLOGY 2013

Stocks in this article: GE

GE Healthcare will introduce several new technologies that demonstrate its ongoing commitment to improving the quality of patient care at ANESTHESIOLOGY 2013, the annual meeting of the American Society of Anesthesiologists, taking place October 12-16 in San Francisco. GE Healthcare will showcase new innovations and advances in life-supporting anesthesia delivery systems, patient monitoring, parameters and accessories and highlight how all of these technologies function together to specifically address the clinical needs in perioperative care.

“Innovation comes in all shapes and sizes,” said Thierry Leclercq, president and CEO, GE Healthcare Life Care Solutions. “At Anesthesiology 2013, we are proud to demonstrate several new technologies – from the industry’s first clinically validated forearm blood pressure cuff to advanced digital anesthesia Carestations* with innovative solutions like ecoFLOW – that can help guide more confident clinician decision-making, help reduce costs and provide more personalized patient care.”

GE Healthcare solutions at ANESTHESIOLOGY 2013 will include:

  • Avance CS 2 with ecoFLOW – This innovative anesthesia delivery system with touch screen technology helps enable fast clinical decision making at the point of care. With ecoFLOW technology, clinicians receive visual guidance to help avoid unnecessarily high or low gas flow rates and help clinicians maintain their desired inspired oxygen concentration, in addition to calculating the cost of agent consumed in real-time.
  • GE CRITIKON* RADIAL-CUF – The GE CRITIKON* RADIAL-CUF is the first clinically validated blood pressure cuff for the adult forearm, designed to help combat inaccurate blood pressure readings for adult obese or overly muscular patients. Upper arm blood pressure cuffs may not properly fit the conical-shaped arms of obese or overly muscular patients. As a result, clinicians often place an upper-arm cuff on a patient’s forearm even though it is not clinically validated there. The GE CRITIKON* RADIAL-CUF blood pressure cuff now provides an accurate and reliable blood pressure determination for these patients.
  • CARESCAPE* Respiratory Module – With dozens of devices in the OR, there is often limited space for critical monitoring equipment. The new, miniaturized CARESCAPE* Respiratory Modules are single-width, enabling full respiratory monitoring while providing more space for other modules.
  • CARESCAPE* Monitor B850 and CARESCAPE* Monitor B650 – New enhancements to GE Healthcare’s scalable, integrated patient monitors help reduce data disruptions and detect potential problems earlier.

There is a critical need for improved connectivity, interoperability and predictive data in today’s OR. Every day, clinicians are faced with a multitude of perioperative devices to help support patient care – many of which do not talk to each other. GE Healthcare is leading the way in interoperability with integrated devices and information systems that bring together traditionally disparate streams of patient data to support efficient, patient-focused care.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,269.43 +200.56 1.18%
S&P 500 1,994.71 +21.97 1.11%
NASDAQ 4,607.2640 +59.43 1.31%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs